7-fluoro-2-[2-(5-nitro-2-furyl)vinyl]-4-(p-hydroxyanilino)-quinazoline | 1033778-70-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 7-fluoro-2-[2-(5-nitro-2-furyl)vinyl]-4-(p-hydroxyanilino)-quinazoline
• 英文别名: 4-[[7-Fluoro-2-[2-(5-nitrofuran-2-yl)ethenyl]quinazolin-4-yl]amino]phenol
• CAS: 1033778-70-9
• 化学式: C₂₀H₁₃FN₄O₄
• 分子量: 392.346
• InChiKey: QBJKTKRTGLOEMA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  29
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  117
• 氢给体数：
  2
• 氢受体数：
  8

文献信息

• Isatine derivatives with neurotrophic activity
  申请人：——

  公开号：US20030040518A1

  公开（公告）日：2003-02-27

  The present invention relates to novel isatin derivatives, pharmaceutical compositions comprising the isatin derivatives of the invention, methods of preparing the isatin derivatives of the invention, their use in the treatment of neurodegenerative diseases and for the regeneration or prevention of degeneration of lesioned and damaged neurons, and methods of treatment of neurodegenerative diseases and for the regeneration or prevention of degeneration of lesioned and damaged neurons.

  本发明涉及新型吲哚酮衍生物，包括本发明的吲哚酮衍生物的药物组合物，制备本发明的吲哚酮衍生物的方法，它们在治疗神经退行性疾病以及在再生或预防受损和受损神经元的退化中的用途，以及治疗神经退行性疾病以及再生或预防受损和受损神经元的方法。
• HALOGENATED QUINAZOLINYL NITROFURANS AS ANTIBACTERIAL AGENTS
  申请人：Chamberland Suzanne

  公开号：US20080146562A1

  公开（公告）日：2008-06-19

  The present invention includes novel compounds of the formula wherein: X is absent, or trans or cis CHCH; R 1 is (C 1 -C 10 )alkyl unsubstituted or substituted by one to three hydroxy, (C 2 -C 10 )alkenyl unsubstituted or substituted by one to three hydroxy, (C 2 -C 10 )alkynyl unsubstituted or substituted by one to three hydroxy, or aryl unsubstituted or substituted by one to three hydroxy; R 2 is hydrogen, alkyl or aryl, wherein R 1 and R 2 when taken together form a (C 2 -C 10 )cycloalkyl unsubstituted or substituted by one to three hydroxy; and R 3 and R 4 are, independently of each other, H, halogen, or wherein: P and R are each independently selected from CH 2 , CH 2 CH 2 and CH 2 CHT, wherein T is alkyl; Q is O, S, NH or NCH 3 ; and Y is absent or —CH 2 CH 2 ) n O—, and n=1 or 2; with the proviso that at least one of R 3 and R 4 is halogen, and that when R 4 is halogen, R 3 is hydrogen and Y is absent, neither R 1 nor R 2 are alkyl; or pharmaceutically acceptable salts thereof. The invention also includes pharmaceutically acceptable formulations of said compounds which exhibit antibiotic activity against a wide spectrum of microorganisms including organisms which are resistant to multiple antibiotic families and are useful as antibacterial agents for treatment or prophylaxis of bacterial infections, or their use as antiseptics, agents for sterilization or disinfection.

  本发明涵盖了新型化合物的公式，其中：X为不存在，或为顺式或反式的CHCH; R1为(C1-C10)烷基，未取代或取代1-3个羟基，(C2-C10)烯基，未取代或取代1-3个羟基，(C2-C10)炔基，未取代或取代1-3个羟基，或芳基，未取代或取代1-3个羟基; R2为氢、烷基或芳基，当R1和R2共同形成一个(C2-C10)环烷基时，未取代或取代1-3个羟基; R3和R4是独立的，为氢、卤素或，其中：P和R各自独立选择为CH2， 和 CHT，其中T为烷基; Q为O、S、NH或NCH3; Y为不存在或— )nO—，n=1或2; 前提是至少R3和R4中的一个是卤素，当R4为卤素时，R3为氢且Y不存在，R1和R2均不是烷基; 或其药学上可接受的盐。本发明还包括所述化合物的药学上可接受的制剂，其对广谱微生物包括对多种抗生素家族抗药性的微生物表现出抗生素活性，并可用作治疗或预防细菌感染的抗菌剂，或用作消毒剂、杀菌剂或消毒剂。
• Isatin derivatives with neurotrophic activity useful in the treatment of diseases mediated by the nerve growth factor (NGF) activation
  申请人：NEUROSEARCH A/S

  公开号：EP1736468A2

  公开（公告）日：2006-12-27

  The present invention relates to novel isatin derivatives of formula (I), pharmaceutical compositions comprising the isatin derivatives of the invention, methods of preparing the isatin derivatives of the invention and their use in the treatment of neurodegenerative diseases and for the regeneration or prevention of degeneration of lesioned and damaged neurons wherein, A represents a group of the formula -C(NOR2)- or -NR2-CO-;

  本发明涉及式(I)的新型异汀衍生物、包含本发明异汀衍生物的药物组合物、制备本发明异汀衍生物的方法及其在治疗神经退行性疾病和再生或预防病变和受损神经元变性中的用途。 其中 A 代表式 -C(NOR2)- 或 -NR2-CO- 的基团；
• US7282511B2
  申请人：——

  公开号：US7282511B2

  公开（公告）日：2007-10-16
• US7410974B2
  申请人：——

  公开号：US7410974B2

  公开（公告）日：2008-08-12